Journal article
Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
Abstract
OBJECTIVE: To compare key features of the new oral anticoagulants (NOACs)-dabigatran, rivaroxaban, and apixaban-and to address questions that arise when comparing the NOACs.
SOURCES OF INFORMATION: PubMed was searched for recent (January 2008 to week 32 of 2013) clinical studies relating to NOAC use for stroke prevention in atrial fibrillation (AF) and for the treatment of acute venous thromboembolism (VTE).
Authors
Douketis J; Bell AD; Eikelboom J; Liew A
Journal
Canadian Family Physician, Vol. 60, No. 11, pp. 989–995
Publication Date
11 2014
ISSN
0008-350X